Tag: Gelatin capsules

Poor Stability of Encapsulated Oils over Product Shelf Life Addressing Poor Stability of Encapsulated Oils over Product Shelf Life Context Encapsulated oils are commonly used in pharmaceutical formulations due to their ability to deliver active ingredients, such as vitamins, omega-3 fatty acids, or essential oils, in a stable and controlled manner. However, oils are highly…

Read More “Poor Stability of Encapsulated Oils over Product Shelf Life” »

Poor Flowability of Powders Leading to Encapsulation Issues Addressing Poor Flowability of Powders Leading to Encapsulation Issues Context The flowability of powders plays a critical role in the manufacturing of capsule formulations, particularly in achieving uniformity in fill weight and ensuring consistent dissolution and bioavailability. Poor flowability of powder blends can lead to inconsistent filling…

Read More “Poor Flowability of Powders Leading to Encapsulation Issues” »

Challenges in Encapsulating APIs with a High Tendency for Degradation Addressing Challenges in Encapsulating APIs with a High Tendency for Degradation Context Active Pharmaceutical Ingredients (APIs) that are prone to degradation are a significant challenge in pharmaceutical formulation, especially when encapsulated in soft or hard gelatin capsules. Degradation of the API during encapsulation, storage, or…

Read More “Challenges in Encapsulating APIs with a High Tendency for Degradation” »

High Variability in Dissolution Due to Poor Powder Blend Homogeneity Addressing High Variability in Dissolution Due to Poor Powder Blend Homogeneity Context Powder blend homogeneity is a critical factor in ensuring consistent dissolution and bioavailability of pharmaceutical products, especially in solid dosage forms like tablets and capsules. High variability in the dissolution profile of a…

Read More “High Variability in Dissolution Due to Poor Powder Blend Homogeneity” »

Incompatibility of Certain Solvents with High-Molecular-Weight APIs Addressing the Incompatibility of Certain Solvents with High-Molecular-Weight APIs Context Formulating high-molecular-weight (HMW) active pharmaceutical ingredients (APIs), such as biologics, peptides, or certain nucleotides, presents unique challenges. These APIs are often poorly soluble in common solvents, and their compatibility with solvents can affect both the stability and bioavailability…

Read More “Incompatibility of Certain Solvents with High-Molecular-Weight APIs” »

Difficulty in Reducing Capsule Brittleness under Low Humidity Conditions Addressing the Difficulty in Reducing Capsule Brittleness under Low Humidity Conditions Context Capsules, particularly soft gelatin capsules, are often sensitive to environmental conditions such as humidity and temperature. Low humidity conditions can lead to an increase in capsule brittleness, which may result in breakage or deformation…

Read More “Difficulty in Reducing Capsule Brittleness under Low Humidity Conditions” »

Limited Excipient Options for Maintaining Capsule Transparency Addressing Limited Excipient Options for Maintaining Capsule Transparency Context Capsules are often preferred for pharmaceutical formulations due to their ease of swallowing, accurate dosing, and ability to mask unpleasant tastes or odors. However, maintaining capsule transparency, particularly in soft gelatin capsules, can present challenges. Transparent capsules offer visual…

Read More “Limited Excipient Options for Maintaining Capsule Transparency” »

Issues with Stability of Probiotic Formulations in Capsule Form Addressing Issues with Stability of Probiotic Formulations in Capsule Form Context Probiotic formulations are essential for supporting gut health and immune function, and they are commonly delivered in capsule form. However, one of the major challenges in developing probiotic capsules is maintaining the stability of the…

Read More “Issues with Stability of Probiotic Formulations in Capsule Form” »

Complexity in Combining Controlled-Release and Immediate-Release Profiles in Capsules Addressing the Complexity in Combining Controlled-Release and Immediate-Release Profiles in Capsules Context Combining controlled-release (CR) and immediate-release (IR) profiles within the same capsule is a complex challenge, particularly for drugs that require both rapid onset of action and sustained therapeutic effects. This combination approach is often…

Read More “Complexity in Combining Controlled-Release and Immediate-Release Profiles in Capsules” »

Difficulty in Developing Fast-Dissolving Capsules Addressing the Difficulty in Developing Fast-Dissolving Capsules Context Fast-dissolving capsules are critical for ensuring rapid onset of action for certain APIs, especially those used for conditions requiring immediate therapeutic effects. However, developing capsules that disintegrate and release their contents quickly can be challenging due to factors such as the physical…

Read More “Difficulty in Developing Fast-Dissolving Capsules” »

Variability in Drug Release Due to Minor Formulation Changes Addressing Variability in Drug Release Due to Minor Formulation Changes Context Minor changes in pharmaceutical formulations, including adjustments to excipient composition, particle size, or manufacturing parameters, can lead to significant variability in drug release profiles. Even small modifications, such as altering the type of binder or…

Read More “Variability in Drug Release Due to Minor Formulation Changes” »

Issues with Formulating Drugs with Strong Oxidative Potential Addressing Issues with Formulating Drugs with Strong Oxidative Potential Context Drugs with strong oxidative potential pose significant challenges during the formulation process, especially when encapsulated in soft gelatin capsules or other dosage forms. These drugs are highly susceptible to degradation due to oxidation, which can lead to…

Read More “Issues with Formulating Drugs with Strong Oxidative Potential” »